Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma

Renal medullary carcinoma (RMC) is an extremely rare and aggressive form of kidney cancer. It is almost exclusively found in young people who carry the sickle cell gene. The sickle cell gene is particularly common in people with an African or Caribbean family background and can cause a group of inherited conditions that affect the red blood […]

read more

Genetic profiling of renal medullary carcinoma paves the way for a potential treatment

Renal medullary carcinoma (RMC) is an aggressive cancer that mainly affects young people of African descent. It is resistant to all targeted agents used to treat other renal cell carcinomas (RCCs) and has limited therapeutic options. This study, published in the journal Cancer Cell analyses the genes of people with renal medullary carcinoma and finds […]

read more

Management of renal medullary carcinoma

Renal medullary carcinoma is a very rare subtype of renal cell carcinoma. This is a very devastating tumour, and it affects mostly patients of African descent, and patients with the sickle-cell trait. These patients in general have a survival of about one year from diagnosis, which is very devastating in this typically young patient population. […]

read more
Showing all 3 results